154 related articles for article (PubMed ID: 35261885)
21. Diagnostic delay and prognosis in primary central nervous system lymphoma compared with glioblastoma multiforme.
Cerqua R; Balestrini S; Perozzi C; Cameriere V; Renzi S; Lagalla G; Mancini G; Montanari M; Leoni P; Scerrati M; Iacoangeli M; Silvestrini M; Luzzi S; Provinciali L
Neurol Sci; 2016 Jan; 37(1):23-29. PubMed ID: 26233232
[TBL] [Abstract][Full Text] [Related]
22. Quantitative Evaluation of Diffusion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Differentiation Between Primary Central Nervous System Lymphoma and Glioblastoma.
Lu S; Wang S; Gao Q; Zhou M; Li Y; Cao P; Hong X; Shi H
J Comput Assist Tomogr; 2017; 41(6):898-903. PubMed ID: 28806317
[TBL] [Abstract][Full Text] [Related]
23. MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: A systematic review and meta-analysis.
Suh CH; Kim HS; Jung SC; Park JE; Choi CG; Kim SJ
J Magn Reson Imaging; 2019 Aug; 50(2):560-572. PubMed ID: 30637843
[TBL] [Abstract][Full Text] [Related]
24. Primary central nervous system lymphoma and atypical glioblastoma: Differentiation using radiomics approach.
Suh HB; Choi YS; Bae S; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
Eur Radiol; 2018 Sep; 28(9):3832-3839. PubMed ID: 29626238
[TBL] [Abstract][Full Text] [Related]
25. Assessment of the Diagnostic Utility of Serum MicroRNA Classification in Patients With Diffuse Glioma.
Ohno M; Matsuzaki J; Kawauchi J; Aoki Y; Miura J; Takizawa S; Kato K; Sakamoto H; Matsushita Y; Takahashi M; Miyakita Y; Ichimura K; Narita Y; Ochiya T
JAMA Netw Open; 2019 Dec; 2(12):e1916953. PubMed ID: 31808923
[TBL] [Abstract][Full Text] [Related]
26. Glioblastoma and primary central nervous system lymphoma: Preoperative differentiation by using MRI-based 3D texture analysis.
Xiao DD; Yan PF; Wang YX; Osman MS; Zhao HY
Clin Neurol Neurosurg; 2018 Oct; 173():84-90. PubMed ID: 30092408
[TBL] [Abstract][Full Text] [Related]
27. Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility-weighted MR imaging.
Kickingereder P; Wiestler B; Sahm F; Heiland S; Roethke M; Schlemmer HP; Wick W; Bendszus M; Radbruch A
Radiology; 2014 Sep; 272(3):843-50. PubMed ID: 24814181
[TBL] [Abstract][Full Text] [Related]
28. Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastasis using arterial spin labeling and dynamic contrast-enhanced magnetic resonance imaging.
Xi YB; Kang XW; Wang N; Liu TT; Zhu YQ; Cheng G; Wang K; Li C; Guo F; Yin H
Eur J Radiol; 2019 Mar; 112():59-64. PubMed ID: 30777220
[TBL] [Abstract][Full Text] [Related]
29. Differentiation of Primary Central Nervous System Lymphoma and High-Grade Glioma with Dynamic Susceptibility Contrast-Derived Metrics: Pilot Study.
Chaganti J; Taylor M; Woodford H; Steel T
World Neurosurg; 2021 Jul; 151():e979-e987. PubMed ID: 34020062
[TBL] [Abstract][Full Text] [Related]
30. Classification of Primary Cerebral Lymphoma and Glioblastoma Featuring Dynamic Susceptibility Contrast and Apparent Diffusion Coefficient.
Eisenhut F; Schmidt MA; Putz F; Lettmaier S; Fröhlich K; Arinrad S; Coras R; Luecking H; Lang S; Fietkau R; Doerfler A
Brain Sci; 2020 Nov; 10(11):. PubMed ID: 33233698
[TBL] [Abstract][Full Text] [Related]
31. [Usefulness and limitation of FDG-PET in the diagnosis of primary central nervous system lymphoma].
Kawai N; Miyake K; Okada M; Yamamoto Y; Nishiyama Y; Tamiya T
No Shinkei Geka; 2013 Feb; 41(2):117-26. PubMed ID: 23378387
[TBL] [Abstract][Full Text] [Related]
32. Does adding FDG-PET to MRI improve the differentiation between primary cerebral lymphoma and glioblastoma? Observer performance study.
Makino K; Hirai T; Nakamura H; Murakami R; Kitajima M; Shigematsu Y; Nakashima R; Shiraishi S; Uetani H; Iwashita K; Akter M; Yamashita Y; Kuratsu J
Ann Nucl Med; 2011 Jul; 25(6):432-8. PubMed ID: 21404136
[TBL] [Abstract][Full Text] [Related]
33. Classifying primary central nervous system lymphoma from glioblastoma using deep learning and radiomics based machine learning approach - a systematic review and meta-analysis.
Guha A; Goda JS; Dasgupta A; Mahajan A; Halder S; Gawde J; Talole S
Front Oncol; 2022; 12():884173. PubMed ID: 36263203
[TBL] [Abstract][Full Text] [Related]
34. Deep learning aided preoperative diagnosis of primary central nervous system lymphoma.
Naser PV; Maurer MC; Fischer M; Karimian-Jazi K; Ben-Salah C; Bajwa AA; Jakobs M; Jungk C; Jesser J; Bendszus M; Maier-Hein K; Krieg SM; Neher P; Neumann JO
iScience; 2024 Feb; 27(2):109023. PubMed ID: 38352223
[TBL] [Abstract][Full Text] [Related]
35. Deep Learning for Automatic Differential Diagnosis of Primary Central Nervous System Lymphoma and Glioblastoma: Multi-Parametric Magnetic Resonance Imaging Based Convolutional Neural Network Model.
Xia W; Hu B; Li H; Shi W; Tang Y; Yu Y; Geng C; Wu Q; Yang L; Yu Z; Geng D; Li Y
J Magn Reson Imaging; 2021 Sep; 54(3):880-887. PubMed ID: 33694250
[TBL] [Abstract][Full Text] [Related]
36. Machine learning based on multi-parametric magnetic resonance imaging to differentiate glioblastoma multiforme from primary cerebral nervous system lymphoma.
Nakagawa M; Nakaura T; Namimoto T; Kitajima M; Uetani H; Tateishi M; Oda S; Utsunomiya D; Makino K; Nakamura H; Mukasa A; Hirai T; Yamashita Y
Eur J Radiol; 2018 Nov; 108():147-154. PubMed ID: 30396648
[TBL] [Abstract][Full Text] [Related]
37. Multiparametric-MRI-Based Radiomics Model for Differentiating Primary Central Nervous System Lymphoma From Glioblastoma: Development and Cross-Vendor Validation.
Xia W; Hu B; Li H; Geng C; Wu Q; Yang L; Yin B; Gao X; Li Y; Geng D
J Magn Reson Imaging; 2021 Jan; 53(1):242-250. PubMed ID: 32864825
[TBL] [Abstract][Full Text] [Related]
38. Permeability measurement using dynamic susceptibility contrast magnetic resonance imaging enhances differential diagnosis of primary central nervous system lymphoma from glioblastoma.
Lee JY; Bjørnerud A; Park JE; Lee BE; Kim JH; Kim HS
Eur Radiol; 2019 Oct; 29(10):5539-5548. PubMed ID: 30877463
[TBL] [Abstract][Full Text] [Related]
39. Differences between primary central nervous system lymphoma and glioblastoma: topographic analysis using voxel-based morphometry.
Yamashita K; Hiwatashi A; Togao O; Kikuchi K; Momosaka D; Hata N; Akagi Y; Suzuki SO; Iwaki T; Iihara K; Honda H
Clin Radiol; 2019 Oct; 74(10):816.e1-816.e8. PubMed ID: 31400805
[TBL] [Abstract][Full Text] [Related]
40. [Value of Minimum Apparent Diffusion Coefficient in Peritumoral Edema in the Differential Diagnosis between Primary Central Nervous System Lymphoma and Glioblastoma].
Li MG; Chen ZY; Liu G; Xiao HF; Chen XJ; Lou X; Ma L
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Apr; 40(2):146-150. PubMed ID: 29724302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
